Report Detail

Request for Sample of this report

Other Patient Monitoring Devices Global Market - Forecast to 2027

  • RnM4214916
    • |
  • 25 September, 2020
    • |
  • Global
    • |
  • 773 Pages
    • |
  • IQ4I Research & Consultancy
    • |
  • Other

Patient monitoring devices assist in continuous measurement of a patient’s health parameters such as heart rate, respiratory rate, blood pressure, blood oxygen saturation and many other parameters which have become a common feature of all healthcare settings. The Patient monitoring global market is expected to grow at a mid single digit CAGR fom 2020 to 2027 to reach $42,974.9 million by 2027. The increase in the rate of surgeries and diseased population requires continuous monitoring, increasing demand for portable and remote patient monitoring and increasing funding and investment in patient monitoring are driving the market growth. However, the high cost of patient monitoring devices, stringent regulatory approvals for products, Patient safety and inaccuracy concerns associated with patient monitoring devices, increased product recalls are restraining the market growth.
The patient monitoring devices global market is segmented based on device, portability, end-users and geography. The devices market is segmented into neuromonitoring, hemodynamic monitoring, blood glucose monitoring, cardiac monitoring, fetal & neonatal care monitoring, respiratory care monitoring, multi-parameter monitoring, temperature monitoring and remote patient monitoring. According to IQ4I research, Blood glucose monitoring commanded the largest revenue in 2020 and expected to grow at a low single digit CAGR from 2020 to 2027. Remote patient monitoring is expected to grow at a high single digit CAGR from 2020 to 2027 due to increasing demand by patients for home healthcare and increasing connectivity of rural areas.
The neuromonitoring devices global market is further segmented into electroencephalography (EEG) devices, cerebral oximeters, intracranial pressure (ICP) monitors, magnetoencephalography (MEG) and electromyography machines (EMG). Among them, the EEG devices segment commanded the largest revenue in 2020 is expected to grow at a high single digit CAGR from 2020 to 2027. Increasing the incidence of neurological diseases, expansion of application to new areas such as pain monitoring are the factors driving the market growth.
The hemodynamic monitoring devices global market is classified into Blood pressure monitors and cardiac output monitors. Among them, the Blood pressure monitoring devices commanded the largest revenue in 2020 and is expected to grow at a mid single digit CAGR from 2020 to 2027. An increase in the incidence of cardiovascular diseases due to lifestyle changes and rising demand for patient monitoring devices in non-hospital settings are the factors driving the market.
The blood glucose monitoring devices global market is classified into SBGM and CGM. Among the segments, CGM generated the largest revenue in 2020 and is expected to grow at a high single digit CAGR from 2020 to 2027.
The cardiac monitoring device global market is further segmented into event monitors, 12-Lead ECG and Holter monitors, among these, Holter monitor commanded the largest revenue in 2020 and expected to grow at a mid single digit CAGR from 2020 to 2027. Event Monitors market is expected to grow at a high single digit CAGR from 2020 to 2027.
The fetal and Neonatal device global market is classified into fetal monitors, fetal Doppler, infant incubators and neonatal monitoring devices. Among these, fetal monitors commanded the largest revenue in 2020 and expected to grow at a low single digit CAGR from 2020 to 2027. Infant Incubators market is expected to grow at a mid single digit CAGR from 2020 to 2027.
The respiratory care monitoring devices global market is classified into capnography, spirometer, Polysomnography (PSG), Pulse oximetry and others. Among these, Pulse oximeter commanded the largest revenue in 2020 and is expected to grow at a low single digit CAGR from 2020 to 2027. Rising incidence of respiratory and cardiac disorders, rising adoption in homecare settings, growing demand for wireless pulse oximeters and launch of convenient fingertip and wrist pulse oximeters are the factors driving the market. The Capnography devices segment is expected to grow a high single digit CAGR from 2020 to 2027.
The Multi-parameter monitoring devices global market is segmented into High acuity, Mid-acuity, and Low-acuity devices. Among the multi-parameter monitoring devices, high acuity devices commanded the largest revenue in 2020 and expected to grow at a low single digit CAGR from 2020 to 2027. The integration of advanced technology within the high-acuity multi-parameter patient monitors has fostered its adoption in intensive care units and hospitals that help in the treatment of several chronic diseases are the factors driving the market and low acuity segment is expected to grow at a low single digit CAGR from 2020 to 2027. Low-acuity monitors usually have a high preference in ambulatory surgical centers and hospitals because they are easy to use, accurate, mobile and low price as compared to the high-acuity multi-parameter patient monitors are making the device of choice.
The temperature monitoring devices global market is classified into digital thermometers, Infrared (IR) thermometers, and others (thermometer strips). Among them, the IR thermometer commanded the largest revenue in 2020 and is expected to grow at a strong mid single digit CAGR from 2020 to 2027. These devices do not involve touching or contacting anybody's surface so the risk of cross-infection is negligible, the increasing prevalence of chronic and infectious diseases driving the market as well.
The remote patient monitoring (RPM) devices are classified into hemodynamic monitoring devices, neuromonitoring devices, cardiac monitoring devices and multi-parameter monitoring devices and others. Among these, the Cardiac monitoring segment commanded the largest revenue in 2020 and is expected to grow at a high single digit CAGR from 2020 to 2027. An increase in the prevalence of the cardiac disorder, an increase in the prevalence of the geriatric population who are more prone to chronic disorders are the factors that increase the usage of RPM devices. Other remote patient monitoring devices such as remote respiratory monitoring devices and home dialysis devices are expected to be the fastest-growing segment with a high double digit CAGR from 2020 to 2027.
The patient monitoring devices global market is further segmented based on the portability into stationary, portable, wearable and implantable. Among these, portable commanded the largest revenue in 2020 and is expected to grow at a mid single digit CAGR from 2020 to 2027.
The patient monitoring devices global market based on end-user is segmented into hospital, ambulatory, homecare and others. Among these, the hospital commanded the largest revenue in 2020 and is expected to grow at a low single digit CAGR from 2020 to 2027. The home care market is expected to be the fastest-growing segment with a mid single digit CAGR from 2020 to 2027 due to the improvement and acceptance of home care devices has increased.
The market based on geographies is segmented into North America, Europe, Asia Pacific and the Rest of the world regions. Among these, North America commanded the largest share in 2020 and the market is expected to grow at a low single digit CAGR from 2020 to 2027. An increase in patient population and an increase in funding on developing patient monitoring devices are the factors driving the market. Asia Pacific is expected to grow at a mid single digit CAGR from 2020 to 2027.
Major players in the patient monitoring devices global market are Medtronic, PLC (Ireland), Dexcom, Inc. (U.S.), Masimo Corporation (Switzerland), Abbott Laboratories (U.S.), Nihon Kohden Corporation (Japan), Edwards Lifesciences Corporation (U.S.), GE Healthcare (U.S.), Koninklijke Philips N.V. (Netherlands), Hill-Rom Holdings, Inc. (U.S.), Natus Medical, Inc. (U.S.), Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (China), and Dragerwerk AG & Co. KGaA (Germany).


1 EXECUTIVE SUMMARY 36

    2 INTRODUCTION 42

    • 2.1 KEY TAKEAWAYS 42
    • 2.2 SCOPE OF THE REPORT 43
    • 2.3 REPORT DESCRIPTION 43
    • 2.4 MARKETS COVERED 46
    • 2.5 STAKEHOLDERS 49
    • 2.6 RESEARCH METHODOLOGY 50
      • 2.6.1 MARKET SIZE ESTIMATION 51
      • 2.6.2 MARKET BREAKDOWN AND DATA TRIANGULATION 54
      • 2.6.3 SECONDARY SOURCES 55
      • 2.6.4 PRIMARY SOURCES 56
      • 2.6.5 KEY DATA POINTS FROM SECONDARY SOURCES 57
      • 2.6.6 KEY DATA POINTS FROM PRIMARY SOURCES 58
      • 2.6.7 ASSUMPTIONS 58

    3 MARKET ANALYSIS 61

    • 3.1 INTRODUCTION 61
    • 3.2 MARKET SEGMENTATION 62
    • 3.3 FACTORS INFLUENCING MARKET 64
      • 3.3.1 DRIVERS AND OPPORTUNITIES 65
        • 3.3.1.1 Increase in the rate of surgeries and diseased population require

      continuous monitoring. 65

      • 3.3.1.2 Increasing demand for portable and remote patient monitoring devices. 66
      • 3.3.1.3 Increasing funding and investment in patient monitoring technologies. 68
      • 3.3.1.4 Increase in demand for patient monitoring devices in emerging nations 69
      • 3.3.1.5 Favorable reimbursement policies 70
      • 3.3.1.6 Technological advancements 71
      • 3.3.1.7 Availability of services such as home healthcare and nursing care increasing

    the demand for the use of patient monitoring devices 73

    • 3.3.2 RESTRAINTS AND THREATS 74
      • 3.3.2.1 High cost of patient monitoring devices 74
      • 3.3.2.2 Patient safety issues and inaccuracy concern associated with patient

    monitoring devices 75

    • 3.3.2.3 Increased product recalls 75
    • 3.3.2.4 Lack of cyber-security in wireless patient monitoring devices 76
    • 3.3.2.5 Stringent regulatory requirements for new products 77
  • 3.4 REGULATORY AFFAIRS 79
    • 3.4.1 INTERNATIONAL ORGANIZATION FOR STANDARDIZATION 79
      • 3.4.1.1 ISO 9001: 2015 Quality Management System 79
      • 3.4.1.2 ISO 13485 Medical Devices 79
    • 3.4.2 U.S. 80
    • 3.4.3 CANADA 81
    • 3.4.4 EUROPE 82
    • 3.4.5 CHINA 83
    • 3.4.6 INDIA 84
    • 3.4.7 JAPAN 86
  • 3.5 TECHNOLOGICAL ADVANCEMENTS 88
    • 3.5.1 BIOSTICKER 88
    • 3.5.2 ARTIFICIAL INTELLIGENCE IN PATIENT MONITORING DEVICES 88
    • 3.5.3 WEARABLE PATIENT MONITORING DEVICES 91
    • 3.5.4 IOT IN PATIENT MONITORING SYSTEM 91
    • 3.5.5 HOME DIALYSIS REMOTE PATIENT MONITORING SYSTEM 93
    • 3.5.6 SMART ALGORITHMS INTEGRATED HOLTER MONITORING SYSTEMS 94
    • 3.5.7 FUNCTIONAL NEAR-INFRARED SPECTROSCOPY (FNIRS) 95
    • 3.5.8 A TRICORDER PHOTOTYPE FOR DIAGNOSIS AND MONITORING OF MULTI PARAMETER AT HOME 95
    • 3.5.9 WEARABLE TECHNOLOGY FOR CONTINUOUS, NON-INVASIVE BLOOD PRESSURE MONITORING 96
    • 3.5.10 SMART SPEAKERS FOR MONITORING CARDIAC ARREST 97
    • 3.5.11 WIRELESS NEONATAL BODY MONITORS 97
    • 3.5.12 LIQUID METAL BIOSENSORS FOR MONITORING 98
  • 3.6 PORTER’S FIVE FORCE ANALYSIS 98
    • 3.6.1 THREAT OF NEW ENTRANTS 99
    • 3.6.2 THREAT OF SUBSTITUTES 100
    • 3.6.3 RIVALRY AMONG EXISTING COMPETITORS 100
    • 3.6.4 BARGAINING POWER OF SUPPLIERS 101
    • 3.6.5 BARGAINING POWER OF BUYERS 101
  • 3.7 SUPPLY CHAIN ANALYSIS 102
  • 3.8 CLINICAL TRIALS 107
  • 3.9 MARKET SHARE ANALYSIS 113
    • 3.9.1 PATIENT MONITORING DEVICES GLOBAL MARKET SHARE ANALYSIS 113
    • 3.9.2 EEG GLOBAL MARKET SHARE ANALYSIS 117
    • 3.9.3 CEREBRAL OXIMETER GLOBAL MARKET SHARE ANALYSIS 119
    • 3.9.4 ICP GLOBAL MARKET SHARE ANALYSIS 121
    • 3.9.5 BP MONITOR GLOBAL MARKET SHARE ANALYSIS 123
    • 3.9.6 CARDIAC OUTPUT MONITORS GLOBAL MARKET SHARE ANALYSIS 125
    • 3.9.7 CONTINUOUS GLUCOSE MONITORING GLOBAL MARKET SHARE

    • ANALYSIS 127

    • 3.9.8 CARDIAC MONITORING DEVICES GLOBAL MARKET SHARE ANALYSIS 129
    • 3.9.9 PULSE OXIMETER GLOBAL MARKET SHARE ANALYSIS 131
    • 3.9.10 CAPNOGRAPHY GLOBAL SHARE ANALYSIS 133
    • 3.9.11 MULTIPARAMETER MONITORS DEVICES GLOBAL MARKET SHARE ANALYSIS 135
    • 3.9.12 REMOTE PATIENT MONIORING DEVICES GLOBAL MARKET SHARE ANALYSIS 137
    • 3.9.13 TEMPERATURE MONITOR GLOBAL MARKET SHARE ANALYSIS 140
    • 3.9.14 MOBILE CARDIAC TELEMETRY GLOBAL MARKET SHARE ANALYSIS 142
  • 3.10 PATIENT MONITORING DEVICES NUMBER OF UNITS SOLD AND

    • INSTALLED BASE 143

    • 3.10.1 NEUROMONITORING DEVICES NUMBER OF UNITS SOLD AND INSTALLED BASE 144
    • 3.10.2 CARDIAC MONITORING DEVICES NUMBER OF UNITS SOLD AND INSTALLED BASE 145
    • 3.10.3 FETAL AND NEONATAL MONITORING DEVICES NUMBER OF UNITS SOLD AND INSTALLED BASE 147
    • 3.10.4 RESPIRATORY MONITORING DEVICES NUMBER OF UNITS SOLD AND INSTALLED BASE 148
    • 3.10.5 TEMPERATURE MONITORING DEVICES NUMBER OF UNITS SOLD AND INSTALLED BASE 150
    • 3.10.6 HEMODYNAMIC MONITORING DEVICES NUMBER OF UNITS SOLD AND INSTALLED BASE 150
    • 3.10.7 MULTI-PARAMETER MONITORING DEVICES NUMBER OF UNITS SOLD AND INSTALLED BASE 151
    • 3.10.8 BLOOD GLUCOSE MONITORING DEVICES NUMBER OF UNITS SOLD AND INSTALLED BASE 153

    4 PATIENT MONITORING DEVICES MARKET, BY DEVICES 154

    • 4.1 INTRODUCTION 154
    • 4.2 NEUROMONITORING DEVICES 157
      • 4.2.1 ELECTROENCEPHALOGRAPH (EEG) 160
        • 4.2.1.1 8-CHANNEL EEG 164
        • 4.2.1.2 21-CHANNEL EEG 166
        • 4.2.1.3 25-CHANNEL EEG 168
        • 4.2.1.4 32-CHANNEL EEG 169
        • 4.2.1.5 40-CHANNEL EEG 170
        • 4.2.1.6 MULTI-CHANNEL EEG 171
      • 4.2.2 CEREBRAL OXIMETER 173
        • 4.2.2.1 CEREBRAL OXIMETER MONITOR 176
        • 4.2.2.2 CEREBRAL OXIMETER SENSORS 178
        • 4.2.2.3 SINGLE EMITTER DUAL DETECTOR 181
        • 4.2.2.4 DUAL EMITTER DUAL DETECTOR 183
        • 4.2.2.5 FOUR EMITTERS DUAL DETECTOR 184
        • 4.2.2.6 FIVE EMITTERS DUAL DETECTOR 185
        • 4.2.2.7 OTHER SENSORS 186
      • 4.2.3 INTRACRANIAL PRESSURE MONITORS (ICP) 188
      • 4.2.4 MAGNETOENCEPHALOGRAPH (MEG) 190
      • 4.2.5 ELECTROMYOGRAPH MACHINES (EMG) 192
    • 4.3 HEMODYNAMIC MONITORING 194
      • 4.3.1 BLOOD PRESSURE MONITORS 197
      • 4.3.2 CARDIAC OUTPUT MONITORING 200
    • 4.4 BLOOD GLUCOSE MONITORS 201
      • 4.4.1 SELF BLOOD GLUCOSE MONITORING (SBGM) 205
        • 4.4.1.1 BLOOD GLUCOSE METER 209
        • 4.4.1.2 BLOOD GLUCOSE TESTING STRIPS 212
        • 4.4.1.3 LANCETS 213
        • 4.4.1.4 OTHERS 215
      • 4.4.2 CONTINUOUS GLUCOSE MONITORING (CGM) 217
        • 4.4.2.1 GLUCOSE SENSORS 220
        • 4.4.2.2 TRANSMITTER AND RECEIVERS 222
    • 4.5 CARDIAC MONITORING DEVICES 223
      • 4.5.1 12-LEADS ECG MONITORS 227
      • 4.5.2 EVENT MONITORS 229
      • 4.5.3 HOLTER MONITORS 231
    • 4.6 FETAL AND NEONATAL MONITORING DEVICES 232
      • 4.6.1 FETAL MONITORS 235
      • 4.6.2 FETAL DOPPLER 238
      • 4.6.3 INFANT INCUBATORS 239
      • 4.6.4 NEONATAL MONITORING DEVICES 241
    • 4.7 RESPIRATORY MONITORING DEVICES 243
      • 4.7.1 CAPNOGRAPHY 246
      • 4.7.2 SPIROMETER 249
        • 4.7.2.1 Volumetric Spirometers 254
        • 4.7.2.2 Flow Measuring Spirometers 255
      • 4.7.3 POLYSOMNOGRAPHY DEVICES 257
      • 4.7.4 PULSE OXIMETERS 259
        • 4.7.4.1 Fingertip pulse oximeters 262
        • 4.7.4.2 Handheld pulse oximeters 264
        • 4.7.4.3 Tabletop Pulse Oximeters 265
        • 4.7.4.4 Other Pulse Oximeters 267
      • 4.7.5 OTHER RESPIRATORY DEVICES 269
    • 4.8 MULTI-PARAMETER MONITORING DEVICES 272
      • 4.8.1 HIGH-ACUITY 276
      • 4.8.2 MID-ACUITY 279
      • 4.8.3 LOW-ACUITY 280
    • 4.9 TEMPERATURE MONITORING DEVICES 282
      • 4.9.1 DIGITAL THERMOMETERS 286
      • 4.9.2 INFRARED THERMOMETERS (IR THERMOMETERS) 288
      • 4.9.3 OTHERS (THERMOMETER STRIPS) 289
    • 4.10 REMOTE PATIENT MONITORING DEVICES (RPM) 291
      • 4.10.1 REMOTE NEUROMONITORING DEVICES 295
      • 4.10.2 REMOTE HEMODYNAMIC MONITORING DEVICES 297
      • 4.10.3 REMOTE CARDIAC MONITORING DEVICES 299
      • 4.10.4 IMPLANTABLE LOOP RECORDER/ECG MONITOR 302
      • 4.10.5 MOBILE CARDIAC TELEMETRY (MCT/MCOT) 304
      • 4.10.6 REMOTE MULTI-PARAMETER MONITORING DEVICES 306
      • 4.10.7 OTHER REMOTE MONITORING DEVICES 307

    5 PATIENT MONITORING DEVICES GLOBAL MARKET, BY PORTABILITY 311

    • 5.1 INTRODUCTION 311
    • 5.2 STATIONARY PATIENT MONITORING 314
    • 5.3 PORTABLE PATIENT MONITORING 316
    • 5.4 WEARABLE PATIENT MONITORING 318
    • 5.5 IMPLANTABLE PATIENT MONITORING 319

    6 PATIENT MONITORING GLOBAL MARKET, BY END-USERS 321

    • 6.1 INTRODUCTION 321
    • 6.2 HOSPITALS 324
    • 6.3 AMBULATORY SURGICAL CENTERS 329
    • 6.4 HOME HEALTHCARE 330
    • 6.5 OTHERS (SLEEP CENTERS, CLINICS/PHYSICIAN OFFICES, HOSPICES) 332

    7 PATIENT MONITORING DEVICES GLOBAL MARKET BY REGION 335

    • 7.1 INTRODUCTION 335
    • 7.2 NORTH AMERICA 339
      • 7.2.1 U.S. 385
      • 7.2.2 REST OF NORTH AMERICA 396
    • 7.3 EUROPE 408
      • 7.3.1 GERMANY 455
      • 7.3.2 FRANCE 464
      • 7.3.3 U.K. 474
      • 7.3.4 REST OF E.U. 484
    • 7.4 APAC 494
      • 7.4.1 JAPAN 541
      • 7.4.2 CHINA 551
      • 7.4.3 INDIA 561
      • 7.4.4 REST OF APAC 571
    • 7.5 ROW 581
      • 7.5.1 BRAZIL 627
      • 7.5.2 REST OF LATAM 638
      • 7.5.3 MIDDLE EAST AND OTHERS 647

    8 COMPETITIVE LANDSCAPE 658

    • 8.1 INTRODUCTION 658
    • 8.2 APPROVALS 659
    • 8.3 AGREEMENTS, PARTNERSHIP AND COLLABORATION 668
    • 8.4 NEW PRODUCT LAUNCH 672
    • 8.5 ACQUISITION 674
    • 8.6 OTHERS 675

    9 MAJOR PLAYER PROFILES 678

    • 9.1 ABBOTT LABORATORIES 678
      • 9.1.1 OVERVIEW 678
      • 9.1.2 FINANCIALS 679
      • 9.1.3 PRODUCT PORTFOLIO 682
      • 9.1.4 KEY DEVELOPMENTS 683
      • 9.1.5 BUSINESS STRATEGY 685
      • 9.1.6 SWOT ANALYSIS 686
    • 9.2 DEXCOM, INC. 687
      • 9.2.1 OVERVIEW 687
      • 9.2.2 FINANCIALS 688
      • 9.2.3 PRODUCT PORTFOLIO 690
      • 9.2.4 KEY DEVELOPMENTS 691
      • 9.2.5 BUSINESS STRATEGY 692
      • 9.2.6 SWOT ANALYSIS 693
    • 9.3 DRAGERWERK AG & CO. KGAA 694
      • 9.3.1 OVERVIEW 694
      • 9.3.2 FINANCIALS 695
      • 9.3.3 PRODUCT PORTFOLIO 698
      • 9.3.4 KEY DEVELOPMENTS 698
      • 9.3.5 BUSINESS STRATEGY 698
      • 9.3.6 SWOT ANALYSIS 699
    • 9.4 EDWARDS LIFESCIENCES CORPORATION. 700
      • 9.4.1 OVERVIEW 700
      • 9.4.2 FINANCIALS 701
      • 9.4.3 PRODUCT PORTFOLIO 704
      • 9.4.4 KEY DEVELOPMENTS 704
      • 9.4.5 BUSINESS STRATEGY 705
      • 9.4.6 SWOT ANALYSIS 706
    • 9.5 GENERAL ELECTRIC COMPANY (GE HEALTHCARE) 707
      • 9.5.1 OVERVIEW 707
      • 9.5.2 FINANCIALS 708
      • 9.5.3 PRODUCT PORTFOLIO 711
      • 9.5.4 KEY DEVELOPMENTS 712
      • 9.5.5 BUSINESS STRATEGY 713
      • 9.5.6 SWOT ANALYSIS 715
    • 9.6 HILL-ROM HOLDINGS, INC. 716
      • 9.6.1 OVERVIEW 716
      • 9.6.2 FINANCIALS 717
      • 9.6.3 PRODUCT PORTFOLIO 719
      • 9.6.4 KEY DEVELOPMENTS 720
      • 9.6.5 BUSINESS STRATEGY 721
      • 9.6.6 SWOT ANALYSIS 722
    • 9.7 KONINKLIJKE PHILIPS N.V. 723
      • 9.7.1 OVERVIEW 723
      • 9.7.2 FINANCIALS 724
      • 9.7.3 PRODUCT PORTFOLIO 726
      • 9.7.4 KEY DEVELOPMENTS 728
      • 9.7.5 BUSINESS STRATEGY 730
      • 9.7.6 SWOT ANALYSIS 731
    • 9.8 MASIMO CORPORATION 732
      • 9.8.1 OVERVIEW 732
      • 9.8.2 FINANCIALS 733
      • 9.8.3 PRODUCT PORTFOLIO 736
      • 9.8.4 KEY DEVELOPMENTS 737
      • 9.8.5 BUSINESS STRATEGY 741
      • 9.8.6 SWOT ANALYSIS 742
    • 9.9 MEDTRONIC, PLC 743
      • 9.9.1 OVERVIEW 743
      • 9.9.2 FINANCIALS 744
      • 9.9.3 PRODUCT PORTFOLIO 747
      • 9.9.4 KEY DEVELOPMENTS 750
      • 9.9.5 BUSINESS STRATEGY 751
      • 9.9.6 SWOT ANALYSIS 752
    • 9.10 NIHON KOHDEN CORPORATION. 753
      • 9.10.1 OVERVIEW 753
      • 9.10.2 FINANCIALS 754
      • 9.10.3 PRODUCT PORTFOLIO 757
      • 9.10.4 KEY DEVELOPMENTS 758
      • 9.10.5 BUSINESS STRATEGY 759
      • 9.10.6 SWOT ANALYSIS 760
    • 9.11 OMRON CORPORATION 761
      • 9.11.1 OVERVIEW 761
      • 9.11.2 FINANCIALS 762
      • 9.11.3 PRODUCT PORTFOLIO 764
      • 9.11.4 KEY DEVELOPMENTS 765
      • 9.11.5 BUSINESS STRATEGY 766
      • 9.11.6 SWOT ANALYSIS 767
    • 9.12 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONIC CO., LTD. 768
      • 9.12.1 OVERVIEW 768
      • 9.12.2 FINANCIALS 769
      • 9.12.3 PRODUCT PORTFOLIO 769
      • 9.12.4 KEY DEVELOPMENTS 770
      • 9.12.5 BUSINESS STRATEGY 770

    Summary:
    Get latest Market Research Reports on Patient Monitoring Devices. Industry analysis & Market Report on Patient Monitoring Devices is a syndicated market report, published as Patient Monitoring Devices Global Market - Forecast to 2027. It is complete Research Study and Industry Analysis of Patient Monitoring Devices market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$4,950.00
    		$6,750.00
    		$9,000.00
    		3,890.70
    		5,305.50
    		7,074.00
    		4,677.75
    		6,378.75
    		8,505.00
    		768,240.00
    		1,047,600.00
    		1,396,800.00
    		417,978.00
    		569,970.00
    		759,960.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo